These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 17108056)

  • 1. The human EGF-TM7 receptor EMR3 is a marker for mature granulocytes.
    Matmati M; Pouwels W; van Bruggen R; Jansen M; Hoek RM; Verhoeven AJ; Hamann J
    J Leukoc Biol; 2007 Feb; 81(2):440-8. PubMed ID: 17108056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative domain modeling of human EGF-like module EMR2 and study of interaction of the fourth domain of EGF with chondroitin 4-sulphate.
    Rani M; Dikhit MR; Sahoo GC; Das P
    J Biomed Res; 2011 Mar; 25(2):100-10. PubMed ID: 23554678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion GPCRs as Modulators of Immune Cell Function.
    Hamann J; Hsiao CC; Lee CS; Ravichandran KS; Lin HH
    Handb Exp Pharmacol; 2016; 234():329-350. PubMed ID: 27832495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.
    Kane AJ; Sughrue ME; Rutkowski MJ; Phillips JJ; Parsa AT
    Neuroreport; 2010 Nov; 21(16):1018-22. PubMed ID: 20827226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
    Chan TA; Yarchoan M; Jaffee E; Swanton C; Quezada SA; Stenzinger A; Peters S
    Ann Oncol; 2019 Jan; 30(1):44-56. PubMed ID: 30395155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced myeloid commitment and increased uptake by macrophages of stem cell-derived HPS2 neutrophils.
    Webbers SD; Aarts CE; Klein B; Koops D; Geissler J; Tool AT; van Bruggen R; van den Akker E; Kuijpers TW
    Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38238087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-related genes predict prognosis and response to immune checkpoint inhibitors in bladder cancer.
    Yang R; Zhang W; Shang X; Chen H; Mu X; Zhang Y; Zheng Q; Wang X; Liu Y
    Front Pharmacol; 2022; 13():1013672. PubMed ID: 36339597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking for the Genes Related to Lung Cancer From Nasal Epithelial Cells by Network and Pathway Analysis.
    Qureshi N; Chi J; Qian Y; Huang Q; Duan S
    Front Genet; 2022; 13():942864. PubMed ID: 35923697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology.
    Lala T; Hall RA
    Physiol Rev; 2022 Oct; 102(4):1587-1624. PubMed ID: 35468004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral blood
    Zhou X; Lei S; Li L; Xu T; Gu W; Ma F; Yang R
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1456-1463. PubMed ID: 34755660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation.
    Maser RL; Calvet JP
    Cell Signal; 2020 Aug; 72():109637. PubMed ID: 32305667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles for G-protein Coupled Receptors in Development and Activation of Macrophages.
    Wang X; Iyer A; Lyons AB; Körner H; Wei W
    Front Immunol; 2019; 10():2031. PubMed ID: 31507616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Adhesion G Protein-Coupled Receptor GPR97/
    Hsiao CC; Chu TY; Wu CJ; van den Biggelaar M; Pabst C; Hébert J; Kuijpers TW; Scicluna BP; I KY; Chen TC; Liebscher I; Hamann J; Lin HH
    Front Immunol; 2018; 9():2830. PubMed ID: 30559745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADGRE1 (EMR1, F4/80) Is a Rapidly-Evolving Gene Expressed in Mammalian Monocyte-Macrophages.
    Waddell LA; Lefevre L; Bush SJ; Raper A; Young R; Lisowski ZM; McCulloch MEB; Muriuki C; Sauter KA; Clark EL; Irvine KM; Pridans C; Hope JC; Hume DA
    Front Immunol; 2018; 9():2246. PubMed ID: 30327653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.
    de Voer RM; Hahn MM; Weren RD; Mensenkamp AR; Gilissen C; van Zelst-Stams WA; Spruijt L; Kets CM; Zhang J; Venselaar H; Vreede L; Schubert N; Tychon M; Derks R; Schackert HK; Geurts van Kessel A; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
    PLoS Genet; 2016 Feb; 12(2):e1005880. PubMed ID: 26901136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.
    Hamann J; Aust G; Araç D; Engel FB; Formstone C; Fredriksson R; Hall RA; Harty BL; Kirchhoff C; Knapp B; Krishnan A; Liebscher I; Lin HH; Martinelli DC; Monk KR; Peeters MC; Piao X; Prömel S; Schöneberg T; Schwartz TW; Singer K; Stacey M; Ushkaryov YA; Vallon M; Wolfrum U; Wright MW; Xu L; Langenhan T; Schiöth HB
    Pharmacol Rev; 2015; 67(2):338-67. PubMed ID: 25713288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gpr97 is essential for the follicular versus marginal zone B-lymphocyte fate decision.
    Wang JJ; Zhang LL; Zhang HX; Shen CL; Lu SY; Kuang Y; Wan YH; Wang WG; Yan HM; Dang SY; Fei J; Jin XL; Wang ZG
    Cell Death Dis; 2013 Oct; 4(10):e853. PubMed ID: 24113187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination.
    Haralambieva IH; Oberg AL; Ovsyannikova IG; Kennedy RB; Grill DE; Middha S; Bot BM; Wang VW; Smith DI; Jacobson RM; Poland GA
    PLoS One; 2013; 8(5):e62149. PubMed ID: 23658707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.
    Tang XL; Wang Y; Li DL; Luo J; Liu MY
    Acta Pharmacol Sin; 2012 Mar; 33(3):363-71. PubMed ID: 22367282
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.